New HIV prevention shots could protect breastfeeding moms and their babies

NCT ID NCT05986084

Ongoing Prevention Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study looks at whether long-acting HIV prevention shots (CAB-LA) are safe and work well for breastfeeding mothers after childbirth. About 500 new mothers in Botswana will get the shots and be followed for 24 months along with their babies. The goal is to see if this method can prevent HIV infection in a high-risk group while keeping both mom and infant healthy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST FEEDING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Breast Feeding HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST FEEDING PRE-EXPOSURE PROPHYLAXIS (PREP)

Contacts and locations

Locations

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
Botswana Harvard AIDS Institute Partnership

Gaborone, Botswana

More trials for these conditions

Other studies related to the condition(s) this trial covers.